Adial Pharmaceuticals ADIL

$ 1.06 -0.93%

Quarterly report 2024-Q3
added 11-13-2024

Adial Pharmaceuticals Financial Statements 2011-2024 | ADIL

Annual Financial Statements Adial Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	2.05 M	406 K	50.2 M	21.2 M	15.7 M	26.1 M	-	-	-	-	-	-	-
Shares	1.66 M	1.07 M	18.6 M	9.85 M	9.85 M	4.76 M	-	-	-	-	-	-	-
Historical Prices	1.23	0.38	2.7	1.7	2.41	5.12	-	-	-	-	-	-	-
Net Income	-5.12 M	-12.7 M	-19.4 M	-10.9 M	-8.59 M	-11.6 M	-1.14 M	-420 K	-818 K	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-6.89 M	-10.9 M	-19.3 M	-10.9 M	-8.24 M	-6.99 M	-995 K	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-6.89 M	-10.9 M	-19.3 M	-10.9 M	-8.24 M	-6.99 M	-994 K	-410 K	-817 K	-	-	-	-
Operating Expenses	6.89 M	10.9 M	19.3 M	-	8.24 M	6.99 M	-	-	-	-	-	-	-
General and Administrative Expenses	5.62 M	8.91 M	9.34 M	5.07 M	4.28 M	6.62 M	813 K	265 K	497 K	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Adial Pharmaceuticals

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	6.41 M	4.29 M	1.66 M	1.22 M	1.2 M	26.5 M	1.07 M	25.7 M	24.3 M	23.2 M	20.9 M	19.8 M	17.6 M	15.9 M	14.4 M	13.6 M	11.3 M	10.5 M	10.4 M	10.3 M	10.2 M	8.25 M	6.86 M	5.55 M	3.56 M	3.27 M	3.27 M	3.27 M	3.27 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-2.19 M	-2.46 M	-	-1.38 M	1.09 M	-2.91 M	-	-3.11 M	-3.85 M	-2.91 M	-	-4.32 M	-4.44 M	-4.83 M	-	-3.34 M	-1.81 M	-2.28 M	-	-1.72 M	-2.13 M	-2.68 M	-	-8.19 M	-1.79 M	-379 K	-	-1.14 M	-1.14 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	99.2 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-2.21 M	-2.29 M	-	-1.36 M	-1.48 M	-2.92 M	-	-3.19 M	-3.83 M	-3.06 M	-	-4.06 M	-4.4 M	-4.84 M	-	-3.34 M	-1.82 M	-2.3 M	-	-1.75 M	-2.16 M	-2.25 M	-	-3.82 M	-1.74 M	-340 K	-	-262 K	-241 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	50.9 K	-	-	-	22.8 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-2.92 M	-	-3.19 M	-3.83 M	-3.06 M	-	-4.06 M	-4.4 M	-4.84 M	-	-3.34 M	-1.82 M	-2.3 M	-	-1.75 M	-2.16 M	-2.25 M	-	-3.82 M	-1.74 M	-339 K	-	-262 K	-241 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	2.21 M	2.29 M	-	1.36 M	1.48 M	2.92 M	-	3.19 M	3.83 M	3.06 M	-	4.06 M	4.4 M	4.84 M	-	3.34 M	1.82 M	2.3 M	-	1.75 M	2.16 M	2.25 M	-	3.82 M	1.74 M	340 K	-	262 K	241 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	1.18 M	1.27 M	-	1.15 M	1.05 M	2.24 M	-	-	-	2.46 M	-	2.37 M	2.08 M	2.79 M	-	1.49 M	931 K	1.24 M	-	881 K	949 K	1.56 M	-	3.63 M	1.66 M	284 K	-	161 K	161 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency